Software As A Medical Device Market Expect To Reach US$ 5.4 Bn By 2032

The global software as a medical device (SaMD) market is expected to reach US$ 1.1 billion in 2022, registering 16.7% CAGR during the forecast period (2022-2032). Sales in the market are projected to surpass US$ 5.4 billion by 2032 as integration of artificial intelligence, and advanced technology is surging in healthcare sector.

Increasing use of Internet of things (IoT) in the healthcare industry and government efforts to improve the infrastructure are likely to drive the growth in software as a medical device market. Further, monitoring blood pressure, respiration rate, continual collecting of particular metrics in case of chronic conditions, and offering remote support are some of the functions of IoT in healthcare. As a result, the adoption of IoT in the healthcare industry will boost the expansion over the forecast period.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7679

Software as a medical device enhances the effectiveness of medical devices and existing treatment programs, resulting in faster and higher-quality data collection and improved health outcomes. As these solutions are faster and less expensive to upgrade than hardware solutions, the demand in the U.S., the U.K., and other developed regions is expected to surge.

Ability to easily seek user input on host devices also contributes to shorter market time, faster product revisions, and faster innovation. As a result, the benefits provided by these solutions are projected to propel the growth in software as a medical device market over the decade.

Regionally, Asia Pacific software as a medical device market will witness significant growth as a result of quick regulatory changes in medical devices and favorable policies across China and India. Furthermore, adequate government rules for developers regarding the design of diagnostics and medical devices are expected to boost the market.

The market for software as a medical device was dominated by PCs and laptops, in terms of device type. The segment is likely to maintain its dominance during the projection period due to technological advancements in laptop designs that enable the installation of smart sensors, which is transforming the compatibility between these devices and the SaMD.

Key Takeaways:

• North America software as a medical device market is expected to register 15.8% CAGR between 2022 and 2032.
• Based on software technology, the artificial intelligence (AI) segment grew at a CAGR of more than 35% over the past decade.
• The U. S is expected to account for a demand share of 90.2% in North America software as a medical device market.
• Japan software as a medical device market is predicted to grow at a CAGR of 17.8% over the upcoming decade.
• Chronic illness and disease management application market will grow by 5.2x between 2022 and 2032.
• Based on application, screening and diagnosis will hold a market share of 53.4% in 2022.

Growth Drivers:

• Introduction of AI-based software applications and the advancement of technology will drive the growth in software as a medical device market.
• The adoption of software as medical devices has substantially enhanced market growth due to the simplicity of handling and faster decision-making.

Restraints:

• Expansion is likely to be hampered by increasing instances of cybercrime and a lack of cybersecurity, which may impede earning consumer confidence.
• Growth of software as a medical device is hampered by their intangible character, which allows for many copies and wide distribution.

𝐒𝐡𝐚𝐫𝐞 𝐘𝐨𝐮𝐫 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬 & 𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬-
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7679

Competitive Landscape:

To maintain their position, key players in the software as a medical device market are adopting organic growth techniques such as new developments and launches. Players in the market are focusing on increasing their capacity as well as their worldwide presence, employing both organic and inorganic growth strategies including acquisitions and partnerships.

For instance,

• In 2022, iCAD, Inc., a global medical technology company offering novel cancer detection and therapeutic solutions, announced today the introduction of a new webinar series, ProFound Insights, ProFound Impact, which will feature client success stories throughout the year.
• In 2022, Hyperfine, Inc., the manufacturer of Swoop, the first FDA-cleared portable magnetic resonance imaging (MRI) systemTM, is pleased to announce that Queen's University and Kingston Health Sciences Centre will deploy a Swoop system as part of their health services for six towns in the James Bay and Hudson Bay Area.
• In December 2020, MaxQ AI, Ltd. has developed a second-generation ACCIPIO clinical platform for the healthcare sector in order to help physicians give "smarter care" through improved clinical workflow.

Key Companies Profiled by Fact.MR

• GE Healthcare
• iCAD Inc.
• Hyperfine Research
• Star
• Tietronix Software, Inc.
• S3 Connected Health
• Ideagen
• BrightInsight, Inc
• Inzentiz
• Zühlke Group
• Orthogonal

𝐆𝐞𝐭 𝐀𝐜𝐜𝐞𝐬𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/checkout/7679

More Valuable Insights on Software as a Medical Device Market
In the latest study, Fact.MR offers a detailed study on global software as a medical device market for the forecast period of 2022 to 2032. This study also highlights key drivers promoting the sales of software as a medical device through detailed segmentation as follows:

By Device Type:

• Smartphones
• Laptops/Desktops
• Wearable Devices

By Software Technology:

• Artificial Intelligence
• Machine Learning

By Application

• Screening and Diagnosis
• Monitoring and Alerting
• Chronic Condition & Disease Management
• Digital Therapeutics

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia & Oceania
• MEA

𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐦𝐨𝐫𝐞 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐛𝐲 𝐅𝐚𝐜𝐭.𝐌𝐑 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡: https://www.prnewswire.com/news-releases/increasing-usage-of-cloud-based-solutions-to-steer-digital-transaction-management-market-past-us-83-25-billion-by-2032--301628185.html

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.